+0.26%
Today
Loading 1D prices…
Company profile
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
Sector
Other
Industry
Services-Management Consulting Services
Exchange
Nasdaq
Display currency
USD
Location
MENLO PARK, CA, United States
Employees
1K
Fiscal year end
0101
CIK
851520
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| FCNFTI Consulting Inc. Common Stock | $3.9B | $3.8B | +7.15% | $8.24 | -2.85% | Hold |
| HURNHuron Consulting Group Inc. Common Stock | $2.5B | $1.7B | +6.18% | $5.84 | +2.21% | Buy |
| GGenpact Limited Common Stock | $5.9B | $5.1B | +10.88% | $3.13 | -2.11% | Hold |
| ASTHAstrana Health Inc. Common Stock | $1.7B | $3.2B | +0.75% | $0.46 | -9.02% | Buy |
| ICFIICF International Inc. Common Stock | $1.6B | $1.9B | +4.91% | $4.95 | -0.89% | Buy |